Sign in
Taking people in United StatesNo phase

Tracks body pressure signals in cardiovascular surgery patients using a monitoring device

Collects physiologic data from adults having heart or blood vessel surgery using the Accuryn device.

Key facts

Who runs it
Potrero Medical
Where
Asheville, Cleveland, Durham, Los Angeles, Louisville, San Francisco, Washington D.C., Weston, and Winston-Salem, United StatesSee the 9 sites
Trial code
Registry title
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
Status
Recruiting
People taking part
2,500 people, planned
Started
21 Dec 2020
Expected to end
31 Dec 2026
Type of study
Observational
Treatments tested
  • Accuryn Monitoring System
Record updated
28 September 2022

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults having heart surgery who are monitored with the Accuryn Monitoring System during the procedure and ICU stay.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Having cardiac surgical intervention(s).
Earlier treatment
For retrospective enrollment, monitored on the Accuryn Monitoring System during the procedure and ICU stay.

Main reasons for not taking part

  • Advanced chronic kidney disease (eGFR below 20 mL/min/1.73m2 within 30 days before the procedure)
  • Unsuitable for the study in the investigator's opinion
  • Vulnerable groups such as pregnant women, prisoners or people detained in a penal institution

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Signed or Verbal Informed Consent as required by IRB (if applicable)
  • Adult (age ≥ 18)
  • Monitored on the Accuryn® Monitoring System during their procedure and ICU stay (for retrospective enrollment)
  • Patient is undergoing cardiac surgical intervention(s)

Who cannot take part

  • Known history of advanced chronic kidney disease defined by an estimated glomerular filtration rate (eGFR) <20 mL/min/1.73m2 within 30 days prior to procedure
  • The patient is unsuitable for the study, in the opinion of the investigator. This may include vulnerable patient populations such as pregnant women, prisoners ,or those detained in a penal institution

Where in United States

  • Mission Health HospitalAsheville, United StatesContact: Leslie McPeters, MSN, FNPTaking people
  • Cleveland ClinicCleveland, United StatesContact: Michael Kot, MDTaking people
  • Duke University HospitalDurham, United StatesContact: Madhav Swaminathan, MDTaking people
  • Cedars-Sinai Medical CenterLos Angeles, United StatesContact: Bev Ann BlackwellNo longer taking part
  • Jewish Hospital / University of LouisvilleLouisville, United StatesContact: Terry Blanton, BSN, RNTaking people
  • San Francisco VA Medical CenterSan Francisco, United StatesContact: Bev Ann BlackwellNo longer taking part
  • George Washington University HospitalWashington D.C., United StatesContact: Gage Parr, MDTaking people
  • Cleveland Clinic FloridaWeston, United StatesContact: Steven Minear, MDTaking people
  • Wake Forest Baptist Medical CenterWinston-Salem, United StatesContact: Bev Ann BlackwellNo longer taking part

About the trial

What the trial wants to find out

The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.

The group in the trial

  • Accuryn Monitoring System

    Observational only (no intervention). Patients undergoing cardiovascular surgical intervention(s) monitored with the Accuryn Monitoring System (per standard of care) during their hospital stay

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Physiologic Signals and Signatures With the Accuryn Monitoring System - A Retrospective and Prospective Analysis (The Accuryn Registry)
Plain-language title
Tracks body pressure signals in cardiovascular surgery patients using a monitoring deviceGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
28 September 2022
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry (NCT04669548) – Frontlight Research